← Back
$KRYS All transactions

Krystal Biotech, Inc.

▼ SELL 10b5-1 Plan

$ Value

$1.5M

Shares

5,700

Price

$272

Filed

Feb 11

Insider

Name

ROMANO KATHRYN

Title

Chief Accounting Officer

CIK

0001801385

Roles

Officer

Transaction Details

Transaction Date

2026-02-09

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

24,118

Footnotes

The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on November 6, 2025, and will terminate on August 31, 2026, subject to early termination in accordance with the terms of the Rule 10b5-1 trading plan, including upon completion of the sale of all of the shares of the Company's common stock subject to the Rule 10b5-1 trading plan. | The transaction was executed in multiple trades ranging from $270.010 to $270.950. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. | The transaction was executed in multiple trades ranging from $271.105 to $272.095. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. | The transaction was executed in multiple trades ranging from $272.1275 to $273.070. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. | The transaction was executed in multiple trades ranging from $273.160 to $274.095. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. | The transaction was executed in multiple trades ranging from $274.305 to $274.815. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. | The transaction was executed in multiple trades ranging from $275.445 to $275.930. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. | The transaction was executed in a single trade. | Represents a bona fide gift of the Company's common stock to a charitable donor-advised fund. | The options vested ratably over a four-year period beginning on February 28, 2022.

Filing Info

Accession No.

0001711279-26-000011

Form Type

4

Issuer CIK

0001711279

ROMANO KATHRYN's History

Date Ticker Type Value
2026-03-02 KRYS $201K
2026-02-27 KRYS M $0
2026-02-27 KRYS F $899K
2026-02-27 KRYS M $0
2026-02-27 KRYS F $66K
2026-02-27 KRYS M $0
2026-02-27 KRYS M $0
2026-02-27 KRYS A $0
2026-02-27 KRYS A $0
2026-02-09 KRYS M $794K

Other Insiders at KRYS (90d)

Insider Bought Sold Last
JANNEY DANIEL $19.4M 2026-02-27
ROSSI DINO A $5.0M 2026-02-19
Krishnan Krish S
President and CEO
$6.6M 2026-03-04
Krishnan Suma
President, R&D
$6.6M 2026-03-04
ROMANO KATHRYN
Chief Accounting Officer
$2.1M 2026-03-02